No Carolina / NY / Florida
Ph: 561.316.3330

HomeEXECUTIVES

Category: EXECUTIVES

Simona Skerjanec Appointed to the...

Simona Skerjanec has led multiple research and development efforts that have resulted in regulatory approvals and launches of commercial therapies in therapeutic areas including neurology and cardiology in the U.S. and other countries.

Patrick Clysdale Joins Direct Sales...

Patrick Clysdale Patrick Clysdale will manage the company's Direct Sales team's southeastern region, which includes automotive, custom-engineered solutions, healthcare, agriculture, and tent and structure customers.

Simona Skerjanec Appointed to the BOD at Avidity Biosciences

Simona Skerjanec has led multiple research and development efforts that have resulted in regulatory approvals and launches of commercial therapies in therapeutic areas including neurology and cardiology in the U.S. and other countries.

John Murphy PhD Appointed GTX Medical BV Chief Technology Officer

John Murphy PhD joins the company with over twenty years of experience in Class I, II, and III medical devices and implantables and has been instrumental in bringing numerous new devices to commercialization.

Dan Myers Appointed CEO of Leo Lens Pharma

Prior to joining Leo Lens Pharma, Dan Myers was the co-founder and Chief Executive Officer of Alimera Sciences, where he continues to serve as chairman of the Board of Directors.

CHPA Welcomes Procter & Gamble’s Paul Gama as Board Chair

Gama is President of Personal Health Care (PHC) for The Procter & Gamble Company (P&G), leading their global healthcare portfolio of OTC medicines, dietary supplements, and consumer medical devices.

Nathan Diers Promoted Vice President of EyeKor Product Development

Yijun Huang, CEO of EyeKor, is thrilled with this new promotion. Huang said, "Nathan Diers has been an integral part of EyeKor's growth.

Charlie Alvarez Appointed Alliance Family of Companies CEO

Charlie Alvarez brings more than 30 years of healthcare leadership experience and most recently served as CEO of DCI Health Technologies, Inc.

David Long Named CFO of Cynosure

David Long will help accelerate the company's business transformation and growth plans under the new leadership of Chief Executive Officer and former Hershey and Unilever executive, Todd Tillemans.

Jay M Moyes Appointed New CFO of Sera Prognostics

Jay M Moyes joins Sera Prognostics as it transitions from rigorous scientific and groundbreaking clinical stage company into a rapidly growing commercial organization.

Roy Tanaka Joins S4 Medical’s Board of Directors

Roy Tanaka brings years of experience to S4. Tanaka joined Biosense Webster, a Johnson & Johnson company, in 1997 as U.S. president, and became its worldwide president in 2004 until his retirement in 2008.

Neil Tween Appointed CFO of Owlstone Medical

Neil Tween joins Owlstone Medical from GW Pharmaceuticals, a publicly listed (NASDAQ: GWPH) pharmaceutical company, where he served as Vice President and Group Financial Controller.

By using this website you agree to accept Medical Device News Magazine Privacy Policy